NDC 59051-9089 - Vitamin K1 Injectable
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59051-9089
- Package NDCs from labels
- 59051-9089-5
- Manufacturer
- Neogen Corporation - Nandino | Sparhawk
- Effective date
- 2012-11-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Vitamin K1 Injectable - Neogen Corporation - Nandino | Sparhawk | Neogen Corporation - Nandino | Sparhawk | 2012-11-27 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59051-9089-5 | Vitamin K1 Injectable | 100 mL in 1 VIAL, MULTI-DOSE | INJECTION | 100 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 59051-9089 | VITAMIN K1 INJECTABLE (PHYTONADIONE) INJECTION [NEOGEN CORPORATION - NANDINO] | 1 | 1 package rows | 20150429_7a32a988-05f1-4b63-8175-5a744c65fa63.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PHYTONADIONE | ACTIVE INGREDIENT | A034SE7857 | VITAMIN K1 INJECTABLE (PHYTONADIONE) INJECTION [NEOGEN CORPORATION - NANDINO] | 1 | |
| PHYTONADIONE | ACTIVE MOIETY | A034SE7857 | VITAMIN K1 INJECTABLE (PHYTONADIONE) INJECTION [NEOGEN CORPORATION - NANDINO] | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | VITAMIN K1 INJECTABLE (PHYTONADIONE) INJECTION [NEOGEN CORPORATION - NANDINO] | 1 | |
| DEXTROSE | INACTIVE INGREDIENT | IY9XDZ35W2 | VITAMIN K1 INJECTABLE (PHYTONADIONE) INJECTION [NEOGEN CORPORATION - NANDINO] | 1 | |
| PEG-40 CASTOR OIL | INACTIVE INGREDIENT | 4ERD2076EF | VITAMIN K1 INJECTABLE (PHYTONADIONE) INJECTION [NEOGEN CORPORATION - NANDINO] | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | VITAMIN K1 INJECTABLE (PHYTONADIONE) INJECTION [NEOGEN CORPORATION - NANDINO] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leukotrap WB system - CP2D | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 42ece7e1-1da1-7e5a-e063-6294a90ac803 | 2026-07-03 | IY9XDZ35W2 | |
| Leukotrap WB System - CP2D | CP2D/AS-3 - ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 44a7d200-13cb-c0b0-e063-6294a90aafad | 2026-07-03 | IY9XDZ35W2 | |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Protective Industrial Products, Inc. | 558e5926-9027-d3f6-e063-6294a90ab121 | 2026-07-02 | Warnings | 059QF0KO0R |
| Fendall 2000 Pure Flow | PURIFIED WATER | Protective Industrial Products, Inc. | 55a1d07e-0006-0c75-e063-6394a90a7acc | 2026-07-02 | Warnings | 059QF0KO0R |
| Sterile Eyesaline Eyewash | STERILE EYESALINE EYEWASH | Protective Industrial Products, Inc. | 55a290e8-8310-8be4-e063-6394a90abdce | 2026-07-02 | Warnings | 059QF0KO0R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Protective Industrial Products, Inc. | 55a261c2-725d-6765-e063-6294a90a3260 | 2026-07-02 | Warnings | 059QF0KO0R |
| Remodulin | TREPROSTINIL | United Therapeutics Corporation | 6c80bb38-e8db-4138-9f0d-dbbf9c673185 | 2026-07-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Leukotrap RC PL System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54eab581-bc48-f9f0-e063-6394a90a4b93 | 2026-06-25 | IY9XDZ35W2 | |
| Chemstat | GLYCERINUM, TARAXACUM OFFICINALE, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BOVISTA, CARBO VEGETABILIS, CARBONEUM SULPHURATUM, COFFEA CRUDA, NITRICUM ACIDUM, NUX VOMICA, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, SULPHUR, ACETYLSALICYLICUM ACIDUM, FORMALINUM, GLONOINUM, INSULINUM (HUMAN), LITHIUM CARBONICUM, TEREBINTHINA, THYROIDINUM (SUIS), ACETICUM ACIDUM, BENZOICUM ACIDUM, BENZYL ALCOHOL, BORICUM ACIDUM, CHLORINUM, CORTISONE ACETICUM, EUGENOL, FOLLICULINUM, ISOPROPYL PALMITATE, LACTICUM ACIDUM, | Energique, Inc. | 2e361b50-9268-4053-b13c-93af64549848 | 2026-06-25 | Warnings | LKG8494WBH |
| Leukotrap WB system - CP2D | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54fdf3cf-41df-af7d-e063-6294a90ab1e6 | 2026-06-24 | IY9XDZ35W2 | |
| Fendall 2000 Pure Flow | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37dead3e-60cb-88ae-e063-6294a90a8f70 | 2026-06-24 | Warnings | 059QF0KO0R |
| Blood Collection System | CP2D/AS-3 TRIPLE WITH SAMPLING SYSTEM | GVS TM INC | 54e8cfd2-f91b-8381-e063-6394a90a3f77 | 2026-06-23 | IY9XDZ35W2 | |
| Leukotrap RC PL System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54e9a497-7a94-44c9-e063-6294a90a84da | 2026-06-23 | IY9XDZ35W2 | |
| Leukotrap RC PL System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54eb0462-cd00-4467-e063-6394a90aa371 | 2026-06-23 | IY9XDZ35W2 | |
| Leukotrap RC System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54eb3c81-5cc8-03c4-e063-6294a90a2065 | 2026-06-23 | IY9XDZ35W2 | |
| Leukotrap RC System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54ebb700-3bcf-d0e3-e063-6394a90a57c8 | 2026-06-23 | IY9XDZ35W2 | |
| Bacteriostatic Water | BACTERIOSTATIC WATER | Fujian Genohope Biotech Ltd. | 54f66b82-c9e5-a2bc-e063-6394a90adbbc | 2026-06-23 | 059QF0KO0R | |
| Humalog | INSULIN LISPRO | Eli Lilly and Company | c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f | 2026-06-16 | Warnings, Adverse reactions | 059QF0KO0R |
| BM BM70 DROPS | ANTIM CURD, FERR MET, PHOSPHORUS, SULPHUR, WIESBADEN, THUJA, VERATRUM ALB | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 54113d1f-e8e7-6b4c-e063-6394a90a0edf | 2026-06-12 | Warnings | 059QF0KO0R |
| BM BM70 DROPS | ANTIM CURD, FERR MET, PHOSPHORUS, SULPHUR, WIESBADEN, THUJA, VERATRUM ALB | BM Private Limited | 53fa21d9-1f80-2e69-e063-6394a90ab9f3 | 2026-06-11 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.